Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Velio Bocci
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Concepts & Ideas
Anatomy
Procedures
Disorders
Sign-in to see full Profile
Network (preview)
32
Paulesu, Luana
28
Pessina, Gian Paolo
17
Naldini, Antonella
15
Muscettola, Michela
13
Corradeschi, Fausto
10
Aldinucci, Carlo
9
Travagli, Valter
9
Valacchi, Giuseppe
8
Zanardi, Iacopo
8
Carraro, Fabio
7
Di Paolo, Nicola
6
Borrelli, Emma
5
Larini, Alessandra
3
Cappelletti, Francesca
3
Di Simplicio, Paolo
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Velio Bocci (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Bocci Velio; Borrelli Emma; Travagli Valter; Zanardi Iacopo
The ozone paradox: ozone is a strong oxidant as well as a medical drug.
Medicinal research reviews 2009;29(4):646-82.
-
2009: Travagli Valter; Zanardi Iacopo; Bocci Velio
Topical applications of ozone and ozonated oils as anti-infective agents: an insight into the patent claims.
Recent patents on anti-infective drug discovery 2009;4(2):130-42.
-
2009: Bocci Velio; Travagli Valter; Zanardi Iacopo
May oxygen-ozone therapy improves cardiovascular disorders?
Cardiovascular & hematological disorders drug targets 2009;9(2):78-85.
-
2009: Bocci Velio; Travagli Valter; Zanardi Iacopo
The failure of HIV vaccines: a new autovaccine may overcome some problems.
Medical hypotheses 2009;72(6):662-4.
-
2008: Zanardi Iacopo; Travagli Valter; Gabbrielli Alessandro; Chiasserini Luisa; Bocci Velio
Physico-chemical characterization of sesame oil derivatives.
Lipids 2008;43(9):877-86.
-
2008: Bocci Velio
Does ozone really "cure" cancer?
International journal of cancer. Journal international du cancer 2008;123(5):1222; author reply 1223.
-
2008: Bocci Velio
Non-specific immunomodulation in chronic heart failure.
Lancet 2008;371(9630):2083; author reply 2084.
-
2007: Travagli Valter; Zanardi Iacopo; Silvietti Antonella; Bocci Velio
A physicochemical investigation on the effects of ozone on blood.
International journal of biological macromolecules 2007;41(5):504-11.
-
2007: Bocci Velio; Zanardi Iacopo; Travagli Valter; Di Paolo Nicola
Oxygenation-ozonation of blood during extracorporeal circulation: in vitro efficiency of a new gas exchange device.
Artificial organs 2007;31(9):743-8.
-
2007: Bocci Velio; Aldinucci Carlo; Mosci Francesca; Carraro Fabio; Valacchi Giuseppe
Ozonation of human blood induces a remarkable upregulation of heme oxygenase-1 and heat stress protein-70.
Mediators of inflammation 2007;2007():26785.
-
2007: Bocci V
The case for oxygen-ozonetherapy.
British journal of biomedical science 2007;64(1):44-9.
-
2006: Bocci Velio
Is it true that ozone is always toxic? The end of a dogma.
Toxicology and applied pharmacology 2006;216(3):493-504.
-
2006: Travagli Valter; Zanardi Iacopo; Bocci Velio
A realistic evaluation of the action of ozone on whole human blood.
International journal of biological macromolecules 2006;39(4-5):317-20.
-
2006: Bocci Velio; Aldinucci Carlo
Biochemical modifications induced in human blood by oxygenation-ozonation.
Journal of biochemical and molecular toxicology 2006;20(3):133-8.
-
2005: Bocci V; Travagli V
How an ill-conceived methodological approach can condemn the medical use of ozone therapy.
International journal of biological macromolecules 2005;37(5):287-8; author reply 289-90.
-
2005: Valacchi G; Fortino V; Bocci V
The dual action of ozone on the skin.
The British journal of dermatology 2005;153(6):1096-100.
-
2005: Di Paolo N; Bocci V; Salvo D P; Palasciano G; Biagioli M; Meini S; Galli F; Ciari I; Maccari F; Cappelletti F; Di Paolo M; Gaggiotti E
Extracorporeal blood oxygenation and ozonation (EBOO): a controlled trial in patients with peripheral artery disease.
The International journal of artificial organs 2005;28(10):1039-50.
-
2005: de Monte Amato; van der Zee Hoyte; Bocci Velio
Major ozonated autohemotherapy in chronic limb ischemia with ulcerations.
Journal of alternative and complementary medicine (New York, N.Y.) 2005;11(2):363-7.
-
2005: Bocci Velio; Larini Alessandra; Micheli Vanna
Restoration of normoxia by ozone therapy may control neoplastic growth: a review and a working hypothesis.
Journal of alternative and complementary medicine (New York, N.Y.) 2005;11(2):257-65.
-
2005: Larini A; Bocci V
Effects of ozone on isolated peripheral blood mononuclear cells.
Toxicology in vitro : an international journal published in association with BIBRA 2005;19(1):55-61.
-
2004: Larini A; Bianchi L; Bocci V
Effect of 4-hydroxynonenal on antioxidant capacity and apoptosis induction in Jurkat T cells.
Free radical research 2004;38(5):509-16.
-
2004: Di Paolo N; Bocci V; Gaggiotti E
Ozone therapy.
The International journal of artificial organs 2004;27(3):168-75.
-
2004: Bocci Velio
Ozone as Janus: this controversial gas can be either toxic or medically useful.
Mediators of inflammation 2004;13(1):3-11.
-
2004: Bocci V; Aldinucci C
Rational bases for using oxygen-ozonetherapy as a biological response modifier in sickle cell anemia and beta-thalassemia: a therapeutic perspective.
Journal of biological regulators and homeostatic agents 2004;18(1):38-44.
-
2003: Larini A; Bianchi L; Bocci V
The ozone tolerance: I) Enhancement of antioxidant enzymes is ozone dose-dependent in Jurkat cells.
Free radical research 2003;37(11):1163-8.
-
2003: Bocci V
How a physiologist viewed and lived with the interferon problem.
Journal of biological regulators and homeostatic agents 2003;17(4):289-94.
-
2002: Di Paolo N; Bocci V; Cappelletti F; Petrini G; Gaggiotti E
Necrotizing fasciitis successfully treated with extracorporeal blood oxygenation and ozonization (EBOO).
The International journal of artificial organs 2002;25(12):1194-8.
-
2002: Aldinucci C; Bellussi L; Monciatti G; Passàli G C; Salerni L; Passàli D; Bocci V
Effects of dietary yoghurt on immunological and clinical parameters of rhinopathic patients.
European journal of clinical nutrition 2002;56(12):1155-61.
-
2001: Bocci V; Di Paolo N; Borrelli E; Larini A; Cappelletti F
Ozonation of blood during extracorporeal circulation. II. Comparative analysis of several oxygenator-ozonators and selection of one type.
The International journal of artificial organs 2001;24(12):890-7.
-
2000: Di Paolo N; Bocci V; Garosi G; Borrelli E; Bravi A; Bruci A; Aldinucci C; Capotondo L
Extracorporeal blood oxygenation and ozonation (EBOO) in man. preliminary report.
The International journal of artificial organs 2000;23(2):131-41.
-
2000: Valacchi G; Bocci V
Studies on the biological effects of ozone: 11. Release of factors from human endothelial cells.
Mediators of inflammation 2000;9(6):271-6.
-
1999: Bocci V; Borrelli E; Valacchi G; Luzzi E
Quasi-total-body exposure to an oxygen-ozone mixture in a sauna cabin.
European journal of applied physiology and occupational physiology 1999;80(6):549-54.
-
1999: Bocci V; Di Paolo N; Garosi G; Aldinucci C; Borrelli E; Valacchi G; Cappelli F; Guerri L; Gavioli G; Corradeschi F; Rossi R; Giannerini F; Di Simplicio P
Ozonation of blood during extracorporeal circulation. I. Rationale, methodology and preliminary studies.
The International journal of artificial organs 1999;22(9):645-51.
-
1999: Bocci V
The oropharyngeal delivery of interferons: where are we and where do we need to go?
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1999;19(8):859-61.
-
1999: Bocci V; Valacchi G; Rossi R; Giustarini D; Paccagnini E; Pucci A M; Di Simplicio P
Studies on the biological effects of ozone: 9. Effects of ozone on human platelets.
Platelets 1999;10(2-3):110-6.
-
1999: Bocci V
Biological and clinical effects of ozone. Has ozone therapy a future in medicine?
British journal of biomedical science 1999;56(4):270-9.
-
1999: Valacchi G; Bocci V
Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets.
Mediators of inflammation 1999;8(4-5):205-9.
-
1998: Naldini A; Sower L; Bocci V; Meyers B; Carney D H
Thrombin receptor expression and responsiveness of human monocytic cells to thrombin is linked to interferon-induced cellular differentiation.
Journal of cellular physiology 1998;177(1):76-84.
-
1998: Bocci V; Valacchi G; Corradeschi F; Aldinucci C; Silvestri S; Paccagnini E; Gerli R
Studies on the biological effects of ozone: 7. Generation of reactive oxygen species (ROS) after exposure of human blood to ozone.
Journal of biological regulators and homeostatic agents 1998;12(3):67-75.
-
1998: Bocci V
Is ozone therapy therapeutic?
Perspectives in biology and medicine 1998;42(1):131-43.
-
1998: Bocci V; Valacchi G; Corradeschi F; Fanetti G
Studies on the biological effects of ozone: 8. Effects on the total antioxidant status and on interleukin-8 production.
Mediators of inflammation 1998;7(5):313-7.
-
1997: Naldini A; Carraro F; Silvestri S; Bocci V
Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells.
Journal of cellular physiology 1997;173(3):335-42.
-
1996: Pessina G P; Paulesu L; Corradeschi F; Aldinucci C; Luzzi E; Bocci V
Pulmonary catabolism of interleukin 6 evaluated by lung perfusion of normal and smoker rats.
The Journal of pharmacy and pharmacology 1996;48(10):1063-7.
-
1996: Bocci V
Ozone as a bioregulator. Pharmacology and toxicology of ozonetherapy today.
Journal of biological regulators and homeostatic agents 1996;10(2-3):31-53.
-
1996: Bocci V
Does ozone therapy normalize the cellular redox balance? Implications for therapy of human immunodeficiency virus infection and several other diseases.
Medical hypotheses 1996;46(2):150-4.
-
1996: Borrelli E; Giomarelli P; Naldini A; Luzzi E; Silvestri S; Gardinali M; Bocci V
Plasma levels of immunosuppressive mediators during cardiopulmonary bypass.
Mediators of inflammation 1996;5(1):51-5.
-
1995: Pessina G P; Paulesu L; Corradeschi F; Luzzi E; Aldinucci C; Tanzini M; Bocci V
Pharmacokinetics and catabolism of tumor necrosis factor-alpha in rat lungs.
Immunopharmacology 1995;29(3):245-50.
-
1995: Pessina G P; Paulesu L; Corradeschi F; Aldinucci C; Luzzi E; Bocci V
Pulmonary catabolism of interferon-gamma evaluated by lung perfusion of both normal and smoke-exposed rats.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(3):225-30.
-
1995: Naldini A; Carraro F; Bocci V
Effects of hypoxia on the antiproliferative activity of human interferons.
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 1995;15(2):137-42.
-
1995: Buonocore G; De Filippo M; Gioia D; Picciolini E; Luzzi E; Bocci V; Bracci R
Maternal and neonatal plasma cytokine levels in relation to mode of delivery.
Biology of the neonate 1995;68(2):104-10.
-
1994: Bocci V; Luzzi E; Corradeschi F; Silvestri S
Studies on the biological effects of ozone: 6. Production of transforming growth factor 1 by human blood after ozone treatment.
Journal of biological regulators and homeostatic agents 1994;8(4):108-12.
-
1994: Naldini A; Cesari S; Bocci V
Effects of hypoxia on the cytotoxicity mediated by tumor necrosis factor-alpha.
Lymphokine and cytokine research 1994;13(4):233-7.
-
1994: Bocci V
Pharmacology and side-effects of interferons.
Antiviral research 1994;24(2-3):111-9.
-
1994: Bocci V
Autohaemotherapy after treatment of blood with ozone. A reappraisal.
The Journal of international medical research 1994;22(3):131-44.
-
1993: Bocci V; Luzzi E; Corradeschi F; Paulesu L; Rossi R; Cardaioli E; Di Simplicio P
Studies on the biological effects of ozone: 4. Cytokine production and glutathione levels in human erythrocytes.
Journal of biological regulators and homeostatic agents 1993;7(4):133-8.
-
1993: Naldini A; Carney D H; Bocci V; Klimpel K D; Asuncion M; Soares L E; Klimpel G R
Thrombin enhances T cell proliferative responses and cytokine production.
Cellular immunology 1993;147(2):367-77.
-
1993: Naldini A; Carraro F; Fleischmann W R; Bocci V
Hypoxia enhances the antiviral activity of interferons.
Journal of interferon research 1993;13(2):127-32.
-
1993: Bocci V; Luzzi E; Corradeschi F; Paulesu L; Di Stefano A
Studies on the biological effects of ozone: 3. An attempt to define conditions for optimal induction of cytokines.
Lymphokine and cytokine research 1993;12(2):121-6.
-
1993: Bocci V; von Bremen K; Corradeschi F; Franchi F; Luzzi E; Paulesu L
Presence of interferon-gamma and interleukin-6 in colostrum of normal women.
Lymphokine and cytokine research 1993;12(1):21-4.
-
1993: Bocci V
Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
Journal of biological regulators and homeostatic agents 1993;7(1):1-6.
-
1993: Bocci V; Carraro F; Zeuli M; Naldini A; Calabresi F
The lymphatic route. VIII. Distribution and plasma clearance of recombinant human interleukin-2 after SC administration with albumin in patients.
Biotherapy (Dordrecht, Netherlands) 1993;6(1):73-7.
-
1993: Bocci V; Paulesu L; Pessina G P
The renal catabolic pathways of cytokines.
Contributions to nephrology 1993;101():55-60.
-
1993: Pessina G P; Bocci V; Carraro F; Naldini A; Paulesu L
The lymphatic route. IX. Distribution of recombinant interferon-alpha 2 administered subcutaneously with oedematogenic drugs.
Physiological research / Academia Scientiarum Bohemoslovaca 1993;42(4):243-50.
-
1993: Pessina G P; Paulesu L; Corradeschi F; Luzzi E; Tanzini M; Di Stefano A; Matteuscci G; Bocci V
Production of tumor necrosis factor alpha by rat alveolar macrophages collected after acute cigarette smoking.
Archivum immunologiae et therapiae experimentalis 1993;41(5-6):343-8.
-
1993: Bocci V; Luzzi E; Corradeschi F; Paulesu L
Studies on the biological effects of ozone: 5. Evaluation of immunological parameters and tolerability in normal volunteers receiving ambulatory autohaemotherapy.
Biotherapy (Dordrecht, Netherlands) 1993;7(2):83-90.
-
1992: Paulesu L; Di Stefano A; Luzzi E; Bocci V; Silvestri S; Nencioni L
Effect of tuftsin and its retro-inverso analogue on the release of interferon (IFN-gamma) and tumor necrosis factor (TNF-alpha) by human leucocytes.
Immunology letters 1992;34(1):7-11.
-
1992: Bocci V
Ozonization of blood for the therapy of viral diseases and immunodeficiencies. A hypothesis.
Medical hypotheses 1992;39(1):30-4.
-
1992: Paulesu L; Pessina G P; Bocci V
Human beta-interferon incubated with muscle homogenate is protected by albumin but not by proteinase inhibitors.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1992;200(3):414-7.
-
1992: Bocci V
Physicochemical and biologic properties of interferons and their potential uses in drug delivery systems.
Critical reviews in therapeutic drug carrier systems 1992;9(2):91-133.
-
1991: Bocci V
Absorption of cytokines via oropharyngeal-associated lymphoid tissues. Does an unorthodox route improve the therapeutic index of interferon?
Clinical pharmacokinetics 1991;21(6):411-7.
-
1991: Paulesu L; Luzzi E; Bocci V
Studies on the biological effects of ozone: 2. Induction of tumor necrosis factor (TNF-alpha) on human leucocytes.
Lymphokine and cytokine research 1991;10(5):409-12.
-
1991: Bocci V
Interleukins. Clinical pharmacokinetics and practical implications.
Clinical pharmacokinetics 1991;21(4):274-84.
-
1991: Bocci V; von Bremen K; Corradeschi F; Luzzi E; Paulesu L
What is the role of cytokines in human colostrum?
Journal of biological regulators and homeostatic agents 1991;5(4):121-4.
-
1991: Paulesu L; Bocci V; King A; Loke Y M
Immunocytochemical localization of interferons in human trophoblast populations.
Journal of biological regulators and homeostatic agents 1991;5(3):81-5.
-
1991: Paulesu L; Bocci V; Pessina G P; Nicoletti C; Boccanera M; Cassone A
Interferon induction in rabbits after intraduodenal administration of a phosphorylated glucomannan-protein fraction of the cell wall of Candida albicans.
Immunology letters 1991;27(3):231-5.
-
1990: Bocci V; Carraro F; Naldini A; Cagol P P; Pasqual E M; Prevaldi C; Casara D
Distribution of human recombinant interferon-alpha 2 in rat plasma, liver, and experimental liver metastases.
Molecular biotherapy 1990;2(4):233-4.
-
1990: Bocci V; Paulesu L
Studies on the biological effects of ozone 1. Induction of interferon gamma on human leucocytes.
Haematologica 1990;75(6):510-5.
-
1990: Bocci V; Carraro F; Naldini A; Borrelli E; Biagi G; Gotti G; Giomarelli P P
Interferon levels in human pulmonary tumors are lower than plasma levels.
Journal of biological regulators and homeostatic agents 1990;4(4):153-6.
-
1990: Bocci V
Is interferon effective after oral administration? The state of the art.
Journal of biological regulators and homeostatic agents 1990;4(2):81-3.
-
1990: Bocci V; Pessina G P; Nicoletti C; Paulesu L
The lymphatic route. VII. Distribution of recombinant human interleukin-2 in rabbit plasma and lymph.
Journal of biological regulators and homeostatic agents 1990;4(1):25-9.
-
1990: Pessina G P; Bocci V; Nicoletti C; Becherucci C; Presentini R; Parente L; Villa L; Tagliabue A; Boraschi D
Metabolic behavior and distribution of the synthetic nonapeptide fragment 163-171 of human IL-1 beta.
Lymphokine research 1990;9(3):371-9.
-
1989: Pessina G P; Muscettola M; Paulesu L; Bocci V
Enhanced induction of plasma interferon after subcutaneous administration in rabbits of poly ICLC with albumin.
Journal of biological regulators and homeostatic agents 1989;3(3):118-21.
-
1988: Bocci V; Pessina G P; Paulesu L; Muscettola M; Valeri A
The lymphatic route. V. Distribution of human natural interferon-beta in rabbit plasma and lymph.
Journal of interferon research 1988;8(5):633-40.
-
1988: Bocci V; Pessina G P; Paulesu L; Nicoletti C
The lymphatic route. VI. Distribution of recombinant interferon-alpha 2 in rabbit and pig plasma and lymph.
Journal of biological response modifiers 1988;7(4):390-400.
-
1988: Bocci V
Central nervous system toxicity of interferons and other cytokines.
Journal of biological regulators and homeostatic agents 1988;2(3):107-18.
-
1988: Bocci V
Roles of interferon produced in physiological conditions. A speculative review.
Immunology 1988;64(1):1-9.
-
1988: Bocci V
Renal catabolism of interferons, interleukins 1 and 2 and tumor necrosis factor.
Contributions to nephrology 1988;68():53-7.
-
1988: Bocci V; Paulesu L; Pessina G P; Nicoletti C
The physiological interferon response. IX. Interferon activity in rabbit lymph after intraduodenal administration of alimentary lectins.
Lymphokine research 1988;7(1):49-59.
-
1987: Pessina G P; Pacini A; Bocci V; Maioli E; Naldini A
Studies on tumor necrosis factor (TNF): II. Metabolic fate and distribution of human recombinant TNF.
Lymphokine research 1987;6(1):35-44.
-
1987: Bocci V; Pacini A; Pessina G P; Maioli E; Naldini A
Studies on tumor necrosis factor (TNF)--I. Pharmacokinetics of human recombinant TNF in rabbits and monkeys after intravenous administration.
General pharmacology 1987;18(4):343-6.
-
1987: Bocci V; Pacini A; Pessina G P; Maioli E
[Metabolism and pharmacokinetics of natural immunomodulators]
Annali dell'Istituto superiore di sanità 1987;23(4):761-3.
-
1986: Bocci V; Muscettola M; Grasso G; Magyar Z; Naldini A; Szabo G
The lymphatic route. 1) Albumin and hyaluronidase modify the normal distribution of interferon in lymph and plasma.
Experientia 1986;42(4):432-3.
-
1986: Bocci V; Muscettola M; Naldini A; Bianchi E; Segre G
The lymphatic route--II. Pharmacokinetics of human recombinant interferon-alpha 2 injected with albumin as a retarder in rabbits.
General pharmacology 1986;17(1):93-6.
-
1986: Bocci V; Muscettola M; Naldini A
The lymphatic route--III. Pharmacokinetics of human natural interferon-beta injected with albumin as a retarder in rabbits.
General pharmacology 1986;17(4):445-8.
-
1985: Bocci V; Pacini A; Pessina G P; Paulesu L; Muscettola M; Lunghetti G
Catabolic sites of human interferon-gamma.
The Journal of general virology 1985;66 ( Pt 4)():887-91.
-
1985: Bocci V; Pessina G P; Pacini A; Paulesu L; Muscettola M; Naldini A; Lunghetti G
Pharmacokinetics of human lymphoblastoid interferon in rabbits.
General pharmacology 1985;16(3):277-9.
-
1985: Pessina G P; Paulesu L; Muscettola M; Skiftas S; Lunghetti G; Bocci V
Interferon production in BCG-sensitized rabbits challenged with PPD.
Immunology letters 1985;10(6):315-8.
-
1984: Bocci V; Pessina G P; Pacini A; Paulesu L; Muscettola M; Mogensen K E
Pulmonary catabolism of interferons: alveolar absorption of 125I-labeled human interferon alpha is accompanied by partial loss of biological activity.
Antiviral research 1984;4(4):211-20.
-
1984: Pacini A; Pessina G P; Paulesu L; Muscettola M; Bocci V
Renal handling of interferons.
Contributions to nephrology 1984;42():60-9.
-
1983: Bocci V; Mogensen K E; Muscettola M; Pacini A; Paulesu L; Pessina G P; Skiftas S
Degradation of human 125I-interferon alpha by isolated perfused rabbit kidney and liver.
The Journal of laboratory and clinical medicine 1983;101(6):857-63.
-
1983: Bocci V; Di Francesco P; Pacini A; Pessina G P; Rossi G B; Sorrentino V
Renal metabolism of homologous serum interferon.
Antiviral research 1983;3(1):53-8.
-
1982: Bocci V; Pacini A; Bandinelli L; Pessina G P; Muscettola M; Paulesu L
The role of liver in the catabolism of human alpha- and beta-interferon.
The Journal of general virology 1982;60(Pt 2):397-400.
-
1982: Bocci V; Pacini A; Muscettola M; Pessina G P; Paulesu L; Bandinelli L
The kidney is the main site of interferon catabolism.
Journal of interferon research 1982;2(2):309-14.
-
1981: Bocci V; Pacini A; Muscettola M; Paulesu L; Pessina G P
Renal metabolism of rabbit serum infection.
The Journal of general virology 1981;55(Pt 2):297-304.
-
1981: Bocci V; Pacini A; Muscettola M; Paulesu L; Pessina G P; Santiano M; Viano I
Renal filtration, absorption and catabolism of human alpha interferon.
Journal of interferon research 1981;1(3):347-52.
Sign-in to see more